201 related articles for article (PubMed ID: 22292081)
1. Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma.
Wilczek E; Szparecki G; Lukasik D; Koperski L; Winiarska M; Wilczynski GM; Wasiutynski A; Gornicka B
PLoS One; 2012; 7(1):e30944. PubMed ID: 22292081
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.
He N; Park K; Zhang Y; Huang J; Lu S; Wang L
Gastroenterology; 2008 Mar; 134(3):793-802. PubMed ID: 18325392
[TBL] [Abstract][Full Text] [Related]
3. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
Hirsch TZ; Negulescu A; Gupta B; Caruso S; Noblet B; Couchy G; Bayard Q; Meunier L; Morcrette G; Scoazec JY; Blanc JF; Amaddeo G; Nault JC; Bioulac-Sage P; Ziol M; Beaufrère A; Paradis V; Calderaro J; Imbeaud S; Zucman-Rossi J
J Hepatol; 2020 May; 72(5):924-936. PubMed ID: 31862487
[TBL] [Abstract][Full Text] [Related]
4. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
[TBL] [Abstract][Full Text] [Related]
5. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
[TBL] [Abstract][Full Text] [Related]
6. Orphan receptor small heterodimer partner suppresses tumorigenesis by modulating cyclin D1 expression and cellular proliferation.
Zhang Y; Xu P; Park K; Choi Y; Moore DD; Wang L
Hepatology; 2008 Jul; 48(1):289-98. PubMed ID: 18537191
[TBL] [Abstract][Full Text] [Related]
7. Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
Ward SC; Waxman S
Semin Liver Dis; 2011 Feb; 31(1):61-70. PubMed ID: 21344351
[TBL] [Abstract][Full Text] [Related]
8. Claudins and tricellulin in fibrolamellar hepatocellular carcinoma.
Patonai A; Erdélyi-Belle B; Korompay A; Somorácz A; Straub BK; Schirmacher P; Kovalszky I; Lotz G; Kiss A; Schaff Z
Virchows Arch; 2011 Jun; 458(6):679-88. PubMed ID: 21503766
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas.
Vivekanandan P; Daniel H; Yeh MM; Torbenson M
Mod Pathol; 2010 Jun; 23(6):790-8. PubMed ID: 20228784
[TBL] [Abstract][Full Text] [Related]
10. RFX-1-dependent activation of SHP-1 inhibits STAT3 signaling in hepatocellular carcinoma cells.
Su JC; Chiang HC; Tseng PH; Tai WT; Hsu CY; Li YS; Huang JW; Ko CH; Lin MW; Chu PY; Liu CY; Chen KF; Shiau CW
Carcinogenesis; 2014 Dec; 35(12):2807-14. PubMed ID: 25322871
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
[TBL] [Abstract][Full Text] [Related]
12. POD-1/TCF21 Reduces SHP Expression, Affecting LRH-1 Regulation and Cell Cycle Balance in Adrenocortical and Hepatocarcinoma Tumor Cells.
França MM; Ferraz-de-Souza B; Lerario AM; Fragoso MC; Lotfi CF
Biomed Res Int; 2015; 2015():841784. PubMed ID: 26421305
[TBL] [Abstract][Full Text] [Related]
13. SHP-1 Acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
Wen LZ; Ding K; Wang ZR; Ding CH; Lei SJ; Liu JP; Yin C; Hu PF; Ding J; Chen WS; Zhang X; Xie WF
Cancer Res; 2018 Aug; 78(16):4680-4691. PubMed ID: 29776962
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.
Kim H; Lee MJ; Kim MR; Chung IP; Kim YM; Lee JY; Jang JJ
Liver; 2000 Apr; 20(2):173-8. PubMed ID: 10847487
[TBL] [Abstract][Full Text] [Related]
15. Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.
Graham RP; Lackner C; Terracciano L; González-Cantú Y; Maleszewski JJ; Greipp PT; Simon SM; Torbenson MS
Hepatology; 2018 Oct; 68(4):1441-1447. PubMed ID: 29222914
[TBL] [Abstract][Full Text] [Related]
16. Anterior gradient-2 is overexpressed by fibrolamellar carcinomas.
Vivekanandan P; Micchelli ST; Torbenson M
Hum Pathol; 2009 Mar; 40(3):293-9. PubMed ID: 18973922
[TBL] [Abstract][Full Text] [Related]
17. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
[TBL] [Abstract][Full Text] [Related]
18. MDM4 expression in fibrolamellar hepatocellular carcinoma.
Karki A; Putra J; Kim SS; Laquaglia MJ; Perez-Atayde AR; Sadri-Vakili G; Vakili K
Oncol Rep; 2019 Oct; 42(4):1487-1496. PubMed ID: 31322272
[TBL] [Abstract][Full Text] [Related]
19. Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP.
Zhang Y; Andrews GK; Wang L
Nucleic Acids Res; 2012 Jun; 40(11):4850-60. PubMed ID: 22362755
[TBL] [Abstract][Full Text] [Related]
20. Fibrolamellar hepatocellular carcinoma coexistent with a hepatocellular carcinoma of common type: report of a case.
Okada K; Kim YI; Nakashima K; Tada I; Yoshida T; Kobayashi M; Yokoyama S
Surg Today; 1993; 23(7):626-31. PubMed ID: 7690275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
